Case Reports
doi: 10.1136/bmj.291.6493.485.
Asymptomatic hyperuricemia and allopurinol induced toxic epidermal necrolysis
- PMID: 3160433
- PMCID: PMC1416317
- DOI: 10.1136/bmj.291.6493.485
Item in Clipboard
Case Reports
Asymptomatic hyperuricemia and allopurinol induced toxic epidermal necrolysis
Br Med J (Clin Res Ed).
.
No abstract available
Similar articles
-
Asymptomatic hyperuricaemia and allopurinol induced toxic epidermal necrolysis.Br Med J (Clin Res Ed). 1985 Jun 29;290(6486):1969-70. doi: 10.1136/bmj.290.6486.1969. Br Med J (Clin Res Ed). 1985. PMID: 3924329 Free PMC article. No abstract available.
-
Fatal Stevens-Johnson syndrome/toxic epidermal necrolysis induced by allopurinol-rituximab-bendamustine therapy.J Oncol Pharm Pract. 2015 Oct;21(5):388-92. doi: 10.1177/1078155214533368. Epub 2014 Jul 7. J Oncol Pharm Pract. 2015. PMID: 25005569
-
Allopurinol and the role of uric acid in hypertension.JAMA. 2009 Jan 21;301(3):270; author reply 270-1. doi: 10.1001/jama.2008.1013. JAMA. 2009. PMID: 19155448 No abstract available.
-
Allopurinol in dermatology.Am J Clin Dermatol. 2010;11(4):225-32. doi: 10.2165/11533190-000000000-00000. Am J Clin Dermatol. 2010. PMID: 20509717 Review.
-
Systemic drug reactions with skin involvement: Stevens-Johnson syndrome, toxic epidermal necrolysis, and DRESS.Clin Dermatol. 2015 Sep-Oct;33(5):538-41. doi: 10.1016/j.clindermatol.2015.05.005. Epub 2015 May 27. Clin Dermatol. 2015. PMID: 26321400 Review.
Cited by
-
Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012.Drug Saf. 2013 Oct;36(10):953-80. doi: 10.1007/s40264-013-0084-0. Drug Saf. 2013. PMID: 23873481
-
Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome.Cochrane Database Syst Rev. 2022 Mar 11;3(3):CD013130. doi: 10.1002/14651858.CD013130.pub2. Cochrane Database Syst Rev. 2022. PMID: 35274741 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources